Schizophrenia and Apolipoprotein E Gene Polymorphism in Serbian Population
Authorized Users Only
2010
Authors
Kecmanović, MiljanaDobričić, Valerija
Dimitrijević, Rajna

Keckarević, Dušan
Savić-Pavićević, Dušanka
Keckarević-Marković, Milica
Ivković, Maja
Romac, Stanka
article (publishedVersion)

Metadata
Show full item recordAbstract
Apolipoprotein E (APOE) gene variants are associated with alterations in brain function and increased risk of Alzheimer's disease (AD) and conflicting results have been reported in schizophrenia. Our results showed no significant differences in APOE allele or genotype frequencies between the Serbian schizophrenic patients and control individuals. However, we observed a possible association between particular subtypes of schizophrenia and APOE epsilon 3/epsilon 3 genotype (p = .01221) and epsilon 4 allele showed a tendency toward positive association with responding to typical neuroleptics. APOE genotypes have no major influence on risk of schizophrenia, treatment and response to conventional antipsychotics, and age of onset in schizophrenia.
Keywords:
APOE / genotyping / neuroleptic / schizophrenia / Serbian populationSource:
International Journal of Neuroscience, 2010, 120, 7, 502-506Publisher:
- Taylor & Francis Ltd, Abingdon
Funding / projects:
DOI: 10.3109/00207451003765956
ISSN: 0020-7454
PubMed: 20583903